About Alexandra Santu

This author has not yet filled in any details.
So far Alexandra Santu has created 47 blog entries.
<br>Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs</br><em> – by Christoph M. Tang, Ann Jerse, Martin C. J. Maiden and William M. Shafer </em>
6 December 2023

Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs – by Christoph M. Tang, ...

more
<br>Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development </br><em> – by Tina Guina and Edward A. Weinstein </em>
29 November 2023

Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein ...

more
<br>Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope</br><em> – by Jacob Madden, Timo Minssen & Aaron S. Kesselheim </em>
27 September 2023

Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope – by Jacob Madden, Timo ...

more
<br>The emerging field of digital antibiotic discovery</br><em> – by Shuangzhe Lin & César de la Fuente</em>
16 August 2023

The emerging field of digital antibiotic discovery – by Shuangzhe Lin & César de la Fuente

more
<br>Market stimulation needed for predictable supply of antibiotics with vulnerable supply chains in Europe</br><em> – by Christine Årdal</em>
10 May 2023

Market stimulation needed for predictable supply of antibiotics with vulnerable supply chains in Europe – by Christine Årdal

more
<br>Access to industry antimicrobial resistance (AMR) susceptibility surveillance data</br><em> – by Rebecca Li & Patricia Bradford</em>
25 January 2023

Access to industry antimicrobial resistance (AMR) susceptibility surveillance data – by Rebecca Li & Patricia Bradford

more
<br>Investing in the future of phage therapy</br><em> – by Jon Iredell & Jessica Sacher</em>
10 January 2023

Investing in the future of phage therapy – by Jon Iredell & Jessica Sacher

more
<br>Lack of access to generic antibiotics and antifungals is an overlooked issue in AMR</br><em> – by Fatema Rafiqi, Moska Hellamand and Martijn van Gerven </em>
17 October 2022

Lack of access to generic antibiotics and antifungals is an overlooked issue in AMR – by Fatema Rafiqi, Moska Hellamand and Martijn van ...

more
<br>Making matters worse: antimicrobial resistance in conflict settings</br><em> – by Jacob Goldberg, Angela Uyen-Cateriano and Gijs Van Gassen </em>
23 June 2022

Making matters worse: antimicrobial resistance in conflict settings – by Jacob Goldberg, Angela Uyen-Cateriano and Gijs Van Gassen

more
<br>Antifungal resistance monitoring, be aware and be prepared! </br><em> – by Stephen Hawser and Ian Morrissey</em>
8 March 2022

Antifungal resistance monitoring, be aware and be prepared! – by Stephen Hawser and Ian Morrissey

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top